Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Goldschmidt

Showing results (351-360 of 539) with videos related to

Pageof 54
Sort By:
Frontiers in Immunology|November 30, 2023
RNA-sequencing based first choice of treatment and determination of risk in multiple myelomaMartina Emde-Rajaratnam, Susanne Beck, Vladimir Benes, et al.
Blood Cancer Journal|January 4, 2023
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myelomaElias K Mai, Stefanie Huhn, Kaya Miah, et al.
Cancer Research|September 4, 2012
GF-15, a novel inhibitor of centrosomal clustering, suppresses tumor cell growth in vitro and in vivoMarc S Raab, Iris Breitkreutz, Simon Anderhub, et al.
Investigative Radiology|September 27, 2022
In Vivo Repeatability and Multiscanner Reproducibility of MRI Radiomics Features in Patients With Monoclonal Plasma Cell Disorders: A Prospective Bi-institutional StudyMarkus Wennmann, Fabian Bauer, André Klein, et al.
Cancer Cell|March 10, 2023
The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patientsMirco J Friedrich, Paola Neri, Niklas Kehl, et al.
Leukemia|September 7, 2021
Publisher Correction: JunB is a key regulator of multiple myeloma bone marrow angiogenesisFengjuan Fan, Stefano Malvestiti, Sonia Vallet, et al.
Blood|March 14, 2013
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 studyGösta Gahrton, Simona Iacobelli, Bo Björkstrand, et al.
Blood Advances|January 4, 2018
Direct evidence for a polygenic etiology in familial multiple myelomaBritt-Marie Halvarsson, Anna-Karin Wihlborg, Mina Ali, et al.
Blood|July 27, 2016
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genesK Martin Kortüm, Elias K Mai, Nur H Hanafiah, et al.
Blood Advances|August 1, 2022
Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MMKatharina Kriegsmann, Calin Manta, Ricarda Schwab, et al.
Pageof 54

Showing results (351-360 of 539) with videos related to

Sort By:
Pageof 54
Frontiers in Immunology|November 30, 2023
RNA-sequencing based first choice of treatment and determination of risk in multiple myelomaMartina Emde-Rajaratnam, Susanne Beck, Vladimir Benes, et al.
Blood Cancer Journal|January 4, 2023
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myelomaElias K Mai, Stefanie Huhn, Kaya Miah, et al.
Cancer Research|September 4, 2012
GF-15, a novel inhibitor of centrosomal clustering, suppresses tumor cell growth in vitro and in vivoMarc S Raab, Iris Breitkreutz, Simon Anderhub, et al.
Investigative Radiology|September 27, 2022
In Vivo Repeatability and Multiscanner Reproducibility of MRI Radiomics Features in Patients With Monoclonal Plasma Cell Disorders: A Prospective Bi-institutional StudyMarkus Wennmann, Fabian Bauer, André Klein, et al.
Cancer Cell|March 10, 2023
The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patientsMirco J Friedrich, Paola Neri, Niklas Kehl, et al.
Leukemia|September 7, 2021
Publisher Correction: JunB is a key regulator of multiple myeloma bone marrow angiogenesisFengjuan Fan, Stefano Malvestiti, Sonia Vallet, et al.
Blood|March 14, 2013
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 studyGösta Gahrton, Simona Iacobelli, Bo Björkstrand, et al.
Blood Advances|January 4, 2018
Direct evidence for a polygenic etiology in familial multiple myelomaBritt-Marie Halvarsson, Anna-Karin Wihlborg, Mina Ali, et al.
Blood|July 27, 2016
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genesK Martin Kortüm, Elias K Mai, Nur H Hanafiah, et al.
Blood Advances|August 1, 2022
Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MMKatharina Kriegsmann, Calin Manta, Ricarda Schwab, et al.
Pageof 54